Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
OCA reports transaction trends under Cost and Market Impact Review program; skilled‑nursing and lab deals spike
Summary
OCA's compliance division reported increased use of the Cost and Market Impact Review (CMIR) process since April 2024, with a notable rise in skilled‑nursing facility and laboratory acquisition notices. Officials said they have waived reviews to date but are actively monitoring suspected unreported transactions and encouraging public tip‑lines.
The Office of Health Care Affordability's compliance team told the advisory committee on June 16 that California's Cost and Market Impact Review (CMIR) program has received rising transaction notices since its April 1, 2024 launch and that certain transaction types—especially skilled‑nursing facility and laboratory acquisitions—have become more frequent. Bridal Kearns, assistant chief counsel for OCA's compliance division, summarized activity: the program handled 10 transactions in 2024 with 16 material change notices and 26 pre‑filing meetings, and continued activity into 2025 with at least six transactions and 10 notices already…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
